News
Displaying 91–100 of 504
-
Atsena Receives FDA Authorization to Launch a Gene Therapy Clinical Trial for XLRS
Research NewsKnown as The Lighthouse Study, the Phase ½ trial is expected to begin in mid-2023
-
Foundation Fighting Blindness and Athletes for Hope Announce Strategic Partnership
Foundation NewsThis partnership will drive awareness for blinding diseases throughout the athletic community.
-
Eric Pierce Receives Proctor Medal for Outstanding Achievements in Retinal Research
Research NewsDuring his Proctor Award Lecture, Dr. Pierce reviewed encouraging clinical trial results for Editas’ CRISPR/Cas9 treatment for people with LCA10
-
Research News
Dr. Tucker is leading the development of GMP facilities for manufacturing clinical grade retinal therapies
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Statement from Jason Menzo about Lyft's Refusal to Accept Rider with Guide Dog.
Foundation NewsAs CEO of an organization committed to those impacted by vision loss, it is disheartening there is still discrimination against visually impaired riders who use ride-sharing apps like Uber and Lyft.
-
Research News
Clinical trial participants with advanced vision loss from RP were able to identify fruits and vegetables
-
Geographic Atrophy: The Advanced Form of Dry AMD
Research NewsGeographic atrophy causes significant central vision loss and remains an unmet medical need.
-
Research News
Most participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
